Literature DB >> 8683086

Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later.

J A Jernigan1, M A Clemence, G A Stott, M G Titus, C H Alexander, C M Palumbo, B M Farr.   

Abstract

OBJECTIVE: To investigate the cause of increasing rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection at a university hospital.
DESIGN: Review of data collected by prospective hospital wide surveillance regarding rates of nosocomial MRSA colonization and infection.
SETTING: A 700-bed university hospital providing primary and tertiary care. PATIENTS: Patients admitted to the hospital between 1986 and 1993 who were found to be infected or colonized with MRSA. MAIN OUTCOME MEASUREMENT: Rates of MRSA infection and colonization.
RESULTS: MRSA infection or colonization was identified in 399 patients (0.18%) admitted during the 8-year study. There was no correlation between the annual rates of MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) infections (P = .66). The frequency of both nosocomial and non-nosocomial cases increased significantly over the last 4 years of the study (P < .001 for trend). The ratio of patients who had acquired MRSA nosocomially to those admitted who already were infected or colonized decreased significantly during the study period (P = .002 for trend). There was a significant increase in the frequency of patients with MRSA being transferred from nursing homes and other chronic care facilities (P = .011). A cost-benefit analysis suggested that surveillance cultures of patients transferred from other healthcare facilities would save between $20,062 and $462,067 and prevent from 8 to 41 nosocomial infections.
CONCLUSIONS: An increase in the incidence of nosocomial MRSA infection was associated with an increased frequency of transfer of colonized patients from nursing homes and other hospitals. The lack of correlation between rates of MRSA and MSSA infections suggested that MRSA infections significantly increased the overall rate of staphylococcal infection. Screening cultures of transfer patients from facilities with a high prevalence of MRSA may offer significant benefit by preventing nosocomial infections and reducing patient days spent in isolation.

Entities:  

Mesh:

Year:  1995        PMID: 8683086     DOI: 10.1086/647042

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  35 in total

1.  Evaluation of the BBL Crystal MRSA ID System for detection of oxacillin resistance in Staphylococcus aureus.

Authors:  G Kampf; C Lecke; A K Cimbal; K Weist; H Rüden
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Evaluation of new medium, oxacillin resistance screening agar base, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens.

Authors:  A E Simor; J Goodfellow; L Louie; M Louie
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Methicillin-Resistant Staphylococcus aureus Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  Use of a regional health information exchange to detect crossover of patients with MRSA between urban hospitals.

Authors:  Abel N Kho; Larry Lemmon; Marie Commiskey; Stephen J Wilson; Clement J McDonald
Journal:  J Am Med Inform Assoc       Date:  2007-12-20       Impact factor: 4.497

5.  Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Authors:  Elizabeth Mostofsky; Marc Lipsitch; Gili Regev-Yochay
Journal:  J Antimicrob Chemother       Date:  2011-07-07       Impact factor: 5.790

6.  A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients.

Authors:  C J Clancy; S M Bartsch; M H Nguyen; D R Stuckey; R K Shields; B Y Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-07       Impact factor: 3.267

7.  Impact of the reinforcement of a methicillin-resistant Staphylococcus aureus control programme: a 3-year evaluation by several indicators in a French university hospital.

Authors:  Matthieu Eveillard; Evelyne Lancien; Arnaud deLassence; Catherine Branger; Guilène Barnaud; Jocelyne-Anne Benlolo; Marie-Laure Joly-Guillou
Journal:  Eur J Epidemiol       Date:  2006-08-17       Impact factor: 8.082

8.  Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital.

Authors:  I Björholt; E Haglind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

9.  The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Authors:  Andrew E Simor; Mark Loeb
Journal:  Can J Infect Dis       Date:  2004-01

10.  Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.

Authors:  Marjan W M Wassenberg; G Ardine de Wit; Ben A van Hout; Marc J M Bonten
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.